{
    "Trade/Device Name(s)": [
        "Dri-STAT\u00ae ACP Reagent",
        "Dri-STAT\u00ae Reagent ACP"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K053612",
    "Predicate Device Reference 510(k) Number(s)": [
        "K821674"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CKB"
    ],
    "Summary Letter Date": "March 22, 2006",
    "Summary Letter Received Date": "March 23, 2006",
    "Submission Date": "December 23, 2005",
    "Regulation Number(s)": [
        "21CFR862.1020"
    ],
    "Regulation Name(s)": [
        "Acid phosphatase (total or prostatic) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total acid phosphatase",
        "Non-prostatic acid phosphatase"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON\u00ae Systems"
    ],
    "Method(s)/Technology(ies)": [
        "User Defined Reagent (UDR) enzymatic assay"
    ],
    "Methodologies": [
        "Enzymatic analysis"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter Dri-STAT ACP Reagent for measurement of total and non-prostatic acid phosphatase in human serum using SYNCHRON Systems",
    "Indications for Use Summary": "Intended for in vitro diagnostic determination of total acid phosphatase and non-prostatic acid phosphatase in human serum as a User Defined Reagent application on SYNCHRON Systems",
    "fda_folder": "Clinical Chemistry"
}